We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Oncosil Medical Ltd | ASX:OSL | Australian Stock Exchange | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.0065 | 0.007 | 0.006 | 0.00 | 20:47:08 |
RNS Number:0032O O&L Acquisition PLC 28 July 2003 EMBARGOED UNTIL 7.00 A.M. MONDAY 28 JULY O&L Acquisition plc - Offer for Osborne & Little plc Offer Wholly Unconditional This announcement is not for release, publication or distribution in or into the United States, Canada, Australia or Japan On 4 July 2003 Altium Capital made an offer (the "Offer"), on behalf of O&L Acquisition plc ("O&L Acquisition"), for the whole of the issued and to be issued share capital of Osborne & Little plc ("Osborne & Little"). O&L Acquisition is pleased to announce that all of the conditions of the Offer have now been satisfied or waived. Accordingly, the Offer is now declared unconditional in all respects. Settlement of the consideration due to Osborne & Little Shareholders who have validly accepted the Offer will be effected in accordance with the terms of the Offer. The Offer (including the Share Alternative) will remain open for acceptance until further notice. As at 3.00 p.m. on 25 July 2003, being the first closing date of the Offer, valid acceptances of the Offer had been received in respect of a total of 5,812,693 Osborne & Little Shares, representing approximately 96.43 per cent. of the entire issued share capital of Osborne & Little. Such figures have been confirmed by Capita IRG plc, who are acting as receiving agent to the Offer. These acceptances include valid acceptances in respect of 4,598,840 Osborne & Little Shares, representing in aggregate approximately 76.30 per cent. of the entire issued share capital of Osborne & Little, received from: (i) all of the Osborne & Little Directors, except Charles Motley, on behalf of themselves and their respective immediate families and related trusts and connected persons (within the meaning of section 346 of the Companies Act) in respect of, in aggregate, 4,232,340 Osborne & Little Shares (representing approximately 70.22 per cent. of the entire issued share capital of Osborne & Little); (ii)NCL Nominees Limited (on behalf of Charles Motley and a related trust), in respect of an aggregate holding of 15,000 Osborne & Little Shares (representing approximately 0.25 per cent. of the entire issued share capital of Osborne & Little); (iii)RC Greig Nominees Limited (on behalf of Mr. Maxwell Ward and members of his family), in respect of, in aggregate, 276,500 Osborne & Little Shares (representing approximately 4.59 per cent. of the entire issued share capital of Osborne & Little); and (iv)BFS Small Companies Dividend Trust plc, in respect of 75,000 Osborne & Little Shares (representing approximately 1.24 per cent. of the entire issued share capital of Osborne & Little); in each case pursuant to irrevocable undertakings to accept the Offer received by O&L Acquisition. Immediately prior to 27 March 2003 (being the business day prior to the commencement of the Offer Period), as far as O&L Acquisition is aware, persons acting or deemed to be acting in concert with O&L Acquisition, owned or controlled 4,232,340 Osborne & Little Shares (representing approximately 70.22 per cent. of the entire issued share capital of Osborne & Little). As far as O&L Acquisition is aware, acceptances of the Offer have been received in respect of all Osborne & Little Shares held by persons acting or deemed to be acting in concert with O&L Acquisition. Save as disclosed above, neither O&L Acquisition nor so far as O&L Acquisition is aware, any person acting or deemed to be acting in concert with O&L Acquisition owned or controlled any Osborne & Little Shares (or rights over such shares) immediately prior to 27 March 2003 (being the business day prior to the commencement of the Offer Period), or, since that date has acquired or agreed to acquire any Osborne & Little Shares (or rights over such shares) and no acceptances of the Offer have been received from such persons acting or deemed to be acting in concert with O&L Acquisition. As sufficient acceptances have been received under the Offer, O&L Acquisition intends to implement the provisions of sections 428 to 430F of the Companies Act to acquire compulsorily all outstanding Osborne & Little Shares. A letter, together with a statutory notice pursuant to section 429 of such Act, will shortly be posted to Shareholders who have not yet accepted the Offer. O&L Acquisition will procure that Osborne & Little applies for the cancellation of the admission to trading of Osborne & Little Shares on AIM. It is anticipated that such cancellation will take effect on 22 August 2003, being the date twenty business days from this date. Following cancellation of admission to trading, Osborne & Little Shares will no longer be traded on a recognised investment exchange and accordingly there will be no market for Osborne & Little Shares and they may be difficult to sell. In addition, Osborne & Little and O&L Acquisition will each be re-registered as a private company in due course. Osborne & Little Shareholders are urged to accept the Offer without delay, as this will enable them to receive the consideration under the Offer sooner than under the compulsory acquisition procedures referred to above. Additional Forms of Acceptance are available from Capita IRG plc on 0870 162 3100. The expressions used in this announcement shall, unless the context otherwise requires, bear the same respective meanings as in the Offer Document posted to Osborne & Little Shareholders on 4 July 2003. For further information, please contact: Sir Peter Osborne / Peter Soar Tel: 020 8675 2255 Chairman / Finance Director Osborne & Little PLC Garry Levin / Mark Dickenson / Alexander Church Tel: 020 7484 4040 Altium Capital Limited Simon Hayes / Megan MacIntyre Tel: 020 7418 8900 KBC Peel Hunt Ltd Altium Capital, which is regulated in the United Kingdom by the Financial Services Authority, is acting exclusively for O&L Acquisition as financial adviser within the meaning of the rules of the Financial Services Authority and for no one else in connection with the Offer and is not advising any other person or treating any other person as its client in relation thereto and will not be responsible to anyone other than O&L Acquisition for providing the protections afforded to clients of Altium Capital, or for giving advice to any other person in relation to the Offer, the contents of this announcement or any other matter referred to herein. KBC Peel Hunt, which is regulated in the United Kingdom by the Financial Services Authority, is acting exclusively for Osborne & Little as financial adviser within the meaning of the rules of the Financial Services Authority and for no one else in connection with the Offer and is not advising any other person or treating any other person as its client in relation thereto and will not be responsible to anyone other than Osborne & Little for providing the protections afforded to clients of KBC Peel Hunt, or for giving advice to any other person in relation to the Offer, the contents of this announcement or any other matter referred to herein. This information is provided by RNS The company news service from the London Stock Exchange END OUPVELFLXDBLBBV
1 Year Oncosil Medical Chart |
1 Month Oncosil Medical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions